D B Mark1, T A Simons. Show Affiliations » 1. Duke Clinical Research Institute, Durham, NC, USA.
Abstract
Mesh： See more » AbciximabAngioplasty, Balloon, Coronary/economicsAntibodies, Monoclonal/economicsAntibodies, Monoclonal/therapeutic useCardiovascular Diseases/economicsCardiovascular Diseases/therapyClinical Trials as TopicCost of IllnessCost-Benefit AnalysisEconomics, PharmaceuticalHospital CostsHumansImmunoglobulin Fab Fragments/economicsImmunoglobulin Fab Fragments/therapeutic usePlatelet Aggregation Inhibitors/economicsPlatelet Aggregation Inhibitors/therapeutic useUnited States
Substances： See more » Antibodies, MonoclonalImmunoglobulin Fab FragmentsPlatelet Aggregation InhibitorsAbciximab
Year: 1999 PMID： 10220613 DOI： 10.1016/s0002-8703(99)70445-x
Source DB: PubMed Journal: Am Heart J ISSN： 0002-8703 Impact factor: 4.749